GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Biovail Corporation (BVF) [hlAlert]

Rating:
Overweight
BVF
up 1,589.92 %

Biovail Corporation (BVF) rated Overweight by Thomas Weisel

Posted on: Thursday,  Dec 17, 2009  8:25 AM ET by Thomas Weisel

Thomas Weisel rated Overweight Valeant Pharmaceuticals International Inc (NYSE: VRX) on 12/17/2009, when the stock price was $13.90.
Since then, Valeant Pharmaceuticals International Inc has gained 1589.93% as of 01/06/2016's recent price of $234.90.
If you would have followed this Thomas Weisel's recommendation on VRX, you would have gained 1589.92% of your investment in 2211 days.

Biovail Corporation (Biovail) is a specialty pharmaceutical company that applies advanced drug-delivery technologies to improve the clinical effectiveness of medicines. The Company is engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The Company has various research and development, clinical research, manufacturing and commercial operations located in Barbados, Canada, the United States and Puerto Rico. Its main therapeutic areas of focus are central nervous system (CNS) disorders, pain management and cardiovascular disease. The primary markets for its products are the United States and Canada. On September 16, 2008, Biovail acquired Prestwick Pharmaceuticals, Inc.

At Thomas Weisel Partners, the role of Research is to contribute to our clients' decision process in ways that lead to better investment decisions. We cover the key growth sectors of the economy including Consumer, Energy, Financial Services, Healthcare, Internet, Media & Telecom, Metals & Mining and Technology.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy